Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 602

Test Your Knowledge #602: A 70-year-old man who has type 2 diabetes, coronary artery disease, and COPD...

A 70-year-old man who has type 2 diabetes, coronary artery disease, and chronic obstructive pulmonary disease is seen for an annual physical examination.

Advertisement

He notes no health-related concerns and has no acute symptoms. He is eating healthy foods but is unable to perform regular physical activity. His blood pressure is 150/90 mm Hg, hemoglobin A1C value is 8%, LDL cholesterol level is 90 mg/dL (2.33 mmol/L), and serum electrolyte values are within normal range. His current medications are glyburide 10 mg twice daily, simvastatin 40 mg daily, and hydrochlorothiazide 25 mg daily. The physician helps the patient set a specific health goal for the next few weeks (i.e., to walk his dog at least 10 minutes 5 days a week after lunch), adds lisinopril 10 mg daily and metformin 500 mg twice daily to the patient's treatment regimen, and provides counseling and information about these new medications.

Which of the following is the most important additional step for supporting this patient?

A. Ask the patient to schedule an appointment if his health status changes

B. Schedule a follow-up appointment in 1 month

C. Refer him to a community exercise program

D. Refer him to a diabetes educator

Click here for correct answer.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 December, 2011 and appeared in  Issue 602

Past five issues: Issue 752 | SGLT-2 Inhibitors Special Edition October 2014 | Diabetes Clinical Mastery Series Issue 211 | Issue 751 | Humulin Insulin Special Edition October 2014 |

2014 Most Popular Articles:

FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014
Two Positive Phase 3 Trials for ITCA 650, a GLP-1 Agonist, in Type 2 Diabetes
Posted October 10, 2014
Stanley Schwartz, MD: A New Way of Classifying Diabetes - The Beta-Cell Centric Approach
Posted September 29, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
New GLP-1 Receptor Agonist as an Alternative to Insulin Glargine?
Posted October 10, 2014
Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Posted October 13, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014
Adding an SGLT2 to Insulin Improved Control
Posted October 17, 2014
GLP-1 Agonist Medications Chart
Posted September 23, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are your patients getting enough glucose strips to manage their diabetes?



Search Articles On Diabetes In Control